Morgan Stanley’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $2.55M | Buy |
|
|||||
|
2019
Q4 | $2.75M | Buy |
|
|||||
|
2019
Q3 | $1.94M | Sell |
|
|||||
|
2019
Q2 | $3.01M | Sell |
|
|||||
|
2019
Q1 | $2.46M | Buy |
|
|||||
|
2018
Q4 | $1.7M | Sell |
|
|||||
|
2018
Q3 | $3.16M | Sell |
|
|||||
|
2018
Q2 | $7.52M | Buy |
|
|||||
|
2018
Q1 | $2.31M | Buy |
|
|||||
|
2017
Q4 | $1.42M | Buy |
|
|||||
|
2017
Q3 | $1.39M | Buy |
|
|||||
|
2017
Q2 | $804K | Sell |
|
|||||
|
2017
Q1 | $2.59M | Sell |
|
|||||
|
2016
Q4 | $3.26M | Buy |
|
|||||
|
2016
Q3 | $428K | Buy |
|
|||||
|
2016
Q2 | $100K | Buy |
|
|||||
|
2016
Q1 | $83K | Buy |
|
|||||
|
2015
Q4 | $101K | Buy |
|
|||||
|
2015
Q3 | $91K | Sell |
|
|||||
|
2015
Q2 | $474K | Sell |
|
|||||
|
2015
Q1 | $2.62M | Buy |
|
|||||
|
2014
Q4 | $3.17M | Sell |
|
|||||
|
2014
Q3 | $4.23M | Sell |
|
|||||
|
2014
Q2 | $3.67M | Buy |
|
|||||
|
2014
Q1 | $3.12M | Buy |
|
|||||
|
2013
Q4 | $3.85M | Sell |
|
|||||
|
2013
Q3 | $5.7M | Buy |
|
|||||
|
2013
Q2 | $4.6M | Buy |
|